HISTOLOGICAL PREPARATIONS IN THE PREVENTION OF DYSTONIA ANDIJAN BRANCH OF KOKAND UNIVERSITY FACULTY OF MEDICINE
Keywords:
Neurohistology, muscle tissue morphology, neuronal plasticity, synaptic transmission, histological preparations, immunohistochemistry, hematoxylin eosin staining (H&E staining), nerve fiber degeneration, neurotransmittersAbstract
This article analyzes the role and effectiveness of histological
(histological) preparations used in the prevention of dystonia. The diagnostic and
prophylactic value of these preparations in reducing neuromuscular dysfunctions and
detecting pathological changes in the central nervous system at an early stage is
highlighted. Also, the possibilities of histological methods in assessing morphological
changes in muscle fibers and nerve cells in the pathogenesis of dystonia are considered
on a scientific basis. The results of the study serve to improve strategies for the early
detection and prevention of dystonia.
References
Burke RE, Fahn S, Marsden CD. Torsion dystonia: a double-blind, prospective
trial
of
high-dosage trihexyphenidyl. Neurology. 1986 Feb;36(2):160–4.
doi:10.1212/WNL.36.2.160.
Fahn S. High dose anticholinergic therapy in dystonia. Neurology.
1983;33(10):1255–60. doi:10.1212/WNL.33.10.1255.
Fernandez HH, et al. Randomized controlled trial of deutetrabenazine for tardive
dyskinesia (ARM-TD study). Neurology. 2017;88(21):2003–2010. Available from:
PMC5440239. doi:10.1212/WNL.0000000000003960.
Hauser RA, et al. KINECT 3: A Phase 3 randomized, double-blind, placebo
controlled trial of valbenazine for tardive dyskinesia. Am J Psychiatry/Neurology
(publication
indexed
PubMed).
2017;
see
PubMed ID 28320223.
doi:10.1212/WNL.000000000000.
